Skip to main content
ORIENTBIO Inc. logo

ORIENTBIO Inc. — Investor Relations & Filings

Ticker · 002630 ISIN · KR7002630002 KO Professional, scientific and technical activities
Open in API
Filings indexed 167 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country KR South Korea
Listing KO 002630

About ORIENTBIO Inc.

https://www.orientbio.co.kr

ORIENTBIO Inc. is a biotechnology company that supports drug discovery and biomedical research. The company's core activities involve the production and supply of laboratory animal models, such as mice and rats, for pharmaceutical companies, universities, and research institutions. In addition to providing research models, ORIENTBIO offers a range of biomedical contract services, including comprehensive health checks and genetic testing. The company also develops and distributes laboratory equipment and apparatus for experimental research.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변경
Regulatory Filings Classification · 95% confidence The document is a Korean regulatory disclosure detailing a significant change in sales or profit structure (over 30%), including summary tables of revenue, profit, financial position, board resolution date, and other compliance notes under K-IFRS. It is not a full annual or interim report, nor an earnings release or investor presentation; it is a mandatory regulatory announcement of a material change. Therefore it falls under the catch-all Regulatory Filings category (RNS).
2026-05-15 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled '임시주주총회 결과' which translates to 'Extraordinary General Meeting (EGM) Results'. It provides detailed voting results for shareholder resolutions, including approval rates and meeting dates. The content is focused on the official results of shareholder votes at a general meeting. The document length is short (1202 characters) and it contains specific voting outcomes rather than just an announcement of a meeting or a report. Therefore, it fits the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2026-05-07 Korean
주식병합결정
Share Issue/Capital Change Classification · 92% confidence The document is a formal announcement detailing the terms and schedule of a share consolidation (reverse stock split), including pre- and post-consolidation share counts, dates for shareholder approval, trading halt, and listing. This is a capital change action specifically involving share consolidation, matching the “Share Issue/Capital Change” category (SHA).
2026-03-31 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 75% confidence The document is a brief regulatory announcement in Korean regarding the setting of the shareholder register closure period (record date) for determining rights holders for an upcoming extraordinary general meeting. It does not present full meeting materials (AGM-R), earnings, dividends, or any detailed report; nor is it a report publication notice. It is a routine regulatory filing of shareholder record date information, which best fits into the fallback category of Regulatory Filings (RNS).
2026-03-31 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 75% confidence The document is a formal convocation notice for an extraordinary general shareholders’ meeting (“임시주주총회소집결의”), listing date, venue, record date, board resolution date and agenda items for shareholder voting. This is not an earnings release, audit or annual report, nor a declaration of voting results, but rather proxy and meeting solicitation materials providing agenda details for voting. Therefore it best fits the Proxy Solicitation & Information Statement category (PSI).
2026-03-31 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a convening notice for an extraordinary shareholders’ meeting (“임시주주총회 소집공고”) and includes agenda items, voting methods (proxy and electronic), management discussion on outside directors’ activities, related-party transactions, and business overview. These materials are distributed to shareholders to provide information and solicit votes. This aligns exactly with the definition for "Proxy Solicitation & Information Statement" (Code: PSI).
2026-03-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.